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Abstract
Testosterone deficiency has been correlated with increased cardiovascular diseases, which
in turn has been associated with increased oxidative stress. Several studies have consid-
ered cholesterol oxidation products (COPs) as oxidative stress biomarkers, since some of
them play pro-oxidant and pro-inflammatory roles. We have previously described the cardio-
protective effects of a dosahexaenoic acid (DHA) supplemented diet on the aortic and
mesenteric artery function of orchidectomized rats. The aim of this study was to investigate
whether impaired gonadal function alters the formation of COPs, as well as the potential pre-
ventive role of a DHA-supplemented diet on that effect. For this purpose, aortic and mesen-
teric artery segments obtained from control and orchidectomized rats, fed with a standard or
supplemented with DHA, were used. The content of the following COPs: 7α-hydroxycholes-
terol, 7β-hydroxycholesterol, 7-ketocholesterol, 5,6α-epoxycholesterol, 5,6β-epoxycholes-
terol, cholestanetriol and 25-hydroxycholesterol, were analyzed by gas chromatography.
The results showed that orchidectomy increased the formation of COPs in arteries from
orchidectomized rats, which may participate in the orchidectomy-induced structural and
functional vascular alterations already reported. The fact that the DHA-supplemented diet
prevented the orchidectomy-induced COPs increase confirms the cardiovascular protective
actions of DHA, which could be of special relevance in mesenteric arterial bed, since it
importantly controls the systemic vascular resistance.
Introduction
An important number of studies have shown a correlation between increased cardiovascular
diseases with testosterone deficiency [1, 2]. It has been demonstrated that sex hormones regu-
late vascular function since sex hormones deprivation alters the release, function and cell sig-
naling pathways of endothelial factors that could lead to vascular dysfunction. Thus, previous
studies from our research group have shown that orchidectomy increased ROS production
PLOS ONE | https://doi.org/10.1371/journal.pone.0185805 October 2, 2017 1 / 16
a1111111111
a1111111111
a1111111111
a1111111111
a1111111111
OPENACCESS
Citation: Villalpando DM, Rojas MM, Garcı´a HS,
Ferrer M (2017) Dietary docosahexaenoic acid
supplementation prevents the formation of
cholesterol oxidation products in arteries from
orchidectomized rats. PLoS ONE 12(10):
e0185805. https://doi.org/10.1371/journal.
pone.0185805
Editor: Wolf-Hagen Schunck, Max Delbrueck
Center for Molecular Medicine, GERMANY
Received: July 17, 2017
Accepted: September 19, 2017
Published: October 2, 2017
Copyright: © 2017 Villalpando et al. This is an open
access article distributed under the terms of the
Creative Commons Attribution License, which
permits unrestricted use, distribution, and
reproduction in any medium, provided the original
author and source are credited.
Data Availability Statement: All relevant data are
within the paper.
Funding: This study was supported by fellowships
(to DMV and to MMR) from the CONACyT
(Mexico) and grants (to MF) from Comunidad de
Madrid (S2013/ABI 2783, “INSPIRA1-CM”) and
Fondo Europeo de Desarrollo Regional. The
funders had no role in study design, data collection
and analysis, decision to publish, or preparation of
the manuscript.
[3, 4] and prostanoids release [5–7], while the production of nitric oxide [8] and the antioxi-
dant capacity [9–10] were reduced.
The increased oxidative stress has been associated to the development of cardiovascular dis-
eases [11, 12]. Thus, oxidative damage of cellular membranes and enzymes by reactive oxygen
and nitrogen species (ROS/RNS) has been described in cardiovascular diseases [13].
Oxidative modification of cholesterol from cell membranes by ROS/RNS leads to the for-
mation of cholesterol oxidation products (COPs), also called oxysterols. COPs can also be
formed by enzymatic oxidation and/or by absorption from the diet [14–16]. Regardless of the
source, COPs have the ability to induce disruption of fine structure, alteration of integrity, flu-
idity, and permeability, and loss of biomembrane functionality [17, 18].
Furthermore, oxysterols have been implicated in the pathogenesis of various diseases
including cardiovascular diseases, cancer, neurological disorders, and aging [19–22]. COPs are
able to modify low-density lipoproteins (LDL) and high-density lipoproteins (HDL) into pro-
atherogenic and pro-inflammatory forms. Oxysterols can also trigger pro-oxidative, pro-
inflammatory and cytotoxic reactions in the different cell types of the vascular wall, including
endothelial cells [23], smooth muscle cells [24–25], fibroblasts [26], monocytes and macro-
phages [27]. Derived from such evidence, COPs have been proposed as potential biomarkers
for non-invasive studies of oxidative stress in vivo [28].
Different studies have demonstrated that consumption of Omega-3 polyunsaturated
fatty acids (PUFAs) such as eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA)
may reduce the risk of developing cardiovascular diseases [29, 30]. The anti-thrombotic,
anti-inflammatory and vasoprotector effects of PUFAs on the cardiovascular system have
been reported [31, 32]. Antioxidant propierties of DHA have been also demonstrated
since it decreased ROS formation and bound to free radicals preventing tissue oxidation
[33–35].
Since it was reported that the lack of sex hormones increases oxidative stress and vascular
inflammation, deteriorating factors that could lead to the development of CVD, it is possible
that formation of oxysterols in the arterial wall could be modified by the loss of gonadal func-
tion. On the other hand, Omega-3 PUFAs may act as a cardioprotective treatment in the oxy-
sterol formation induced by orchidectomy. Therefore, the purpose of the present study was to
determine the effects of orchidectomy on the formation of the main oxysterols recognized as
products of cholesterol autoxidation [36] (7α-hydroxycholesterol, 7β-hydroxycholesterol,
7-ketocholesterol, 5,6α-epoxycholesterol, 5,6β-epoxycholesterol, cholestanetriol and 25-hydro-
xycholesterol) in the arterial wall of the aorta and mesenteric artery, as well as the possible pre-
ventive effect of a DHA-supplemented diet on COPs formation.
Materials and methods
Animals, diets and experimental groups
Male Sprague-Dawley rats (18-week-old) were purchased from Envigo (Mexico City). Rats
were housed in stainless steel cages in a temperature-controlled (23 ± 2˚C) room, under
12-hour light/dark cycles and standard feeding with fodder and water ad libitum. After 4
weeks of adaptation, animals were fed a maintenance diet for rodents (2018S Teklad global
18% protein rodent diets, Envigo, Madison, WI, USA) supplemented with fat (5%). The con-
trols-diet groups were supplemented with sunflower oil (5%) and the DHA groups with 4.7%
MEG-31 (Ocean Nutrition Canada Ltd., Dartmouth, NS, CA) and adjusted to 5% with sun-
flower oil. Nutrient content and energy distribution of each diet is summarized in Table 1.
After 2 weeks on the diet, animals were divided into two groups: control and orchidectomized
males. Male sex hormone deprivation was induced by orchidectomy at 24 weeks-old under
Docosahexaenoic acid and cholesterol oxidation products
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injectable anesthesia with Ketamine-Xylazine (80 mg/kg ket plus 10 mg/kg xil; IP). Rats were
treated with 2 mg/kg meloxicam SC (Metacam 5 mg/mL; Boehringer Ingelheim) and with 50
mg/kg ibuprofen immediately after surgery, via IP administration for 5 days. The observation
of seminal vesicles atrophy confirmed successful surgery. Animals were maintained under the
experimental diets for six more weeks. At the end of the treatment, rats were sacrificed by
ether inhalation and decapitation. The mesenteric artery and the aorta were carefully dissected
out, cleaned of connective tissue and placed in Krebs-Henseleit solution (KHS) containing, in
mmol/L: NaCl 115, CaCl2 2.5, KCl 4.6, KH2PO4 1.2, MgSO4 1.2, NaHCO3 25, glucose 11.1,
Na2 EDTA 0.03 at 4˚C. The investigation was performed in compliance with the Guide for the
Care and Use of Laboratory Animals published by the USA National Institutes of Health (NIH
publication No. 85.23 revised 1985), and approved by the Ethical Committee of the Universi-
dad Autónoma de Madrid according to directives of the Ministerio de Agricultura, Pesca y Ali-
mentacio´n of Spain (PROEX 202/16).
Determination of cholesterol and COPs in arterial tissue samples
Lipids extraction. Two aortic and two mesenteric rings (ca. 3 mm length) from each ani-
mal (from the all experimental group of rats) were individually weighed, thawed and subjected
to total lipid extraction, as described by Folch et al. [37] with some modification [16]. Briefly,
arterial rings were homogenized in 1 mL of PBS at 4˚C containing BHT (0.05%). Each arterial
homogenate was mixed with 16 mL of the Folch solution (chloroform-methanol 2:1 v/v) and
0.01% BHT. Then, 3 mL of NaCl aqueous solution (0.73%) were added. The resulting mixture
was separated by centrifugation. The upper phase was discarded and the lipids were collected
from the organic layer (lower phase). A mixture of chloroform-methanol-0.73% NaCl (3:48:47
v/v/v, 7.5 mL) was added to the recovered phase and then left at 4˚C for 4 h to allow separation.
The lower phase was recovered and then filtered through anhydrous sodium sulfate. Subse-
quently, the extract was resuspended in chloroform with BHT (0.02%) and frozen at -20˚C
until used.
Saponification. Cold saponification was performed according to the method of Mene´n-
dez-Carreño et al. [38] to remove glycerides, free fatty acids and water-soluble impurities, as
well as to release the esterified COPs. For sample preparation, each lipidic extract from the
arterial tissue samples was added with 13 μg of the internal standard, 19-hydroxycholesterol
(19-OH) (disolved in n-hexane:isopropanol, 4:1 v/v) for COPs quantification and with 1 mg of
5α-colestane (disolved in n-hexane: isopropanol, 4:1 v/v) as an internal standard for the quan-
tification of cholesterol. The mixture was then dried under stream of nitrogen and mixed with
3 mL of a KOH solution in methanol (4 mol/L or 4 N) with BHT (0.05%), wrapped with
Table 1. Nutrient and energy content of experimental diets.
Macronutrient Control diet (g/100g) DHA diet (g/100g)
Crude protein 18.6 18.6
Fat 11.2 11.2
Carbohydrate (available) 44.2 44.2
Crude Fiber 3.5 3.5
Neutral Detergent Fiber 14.7 14.7
Ash 5.3 5.3
Sunflower oil 5.0 0.3
DHA+EPA 0 4.7
Energy Density kcal/100g 310.0 310.0
https://doi.org/10.1371/journal.pone.0185805.t001
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aluminium foil and subjected to orbital shaking (300 rpm) at room temperature for 18 h to
produce saponification.
For extraction of the unsaponifiable matter, 10 mL of dichloromethane and 5 mL of citric
acid (0.1% in double-distilled water) were added to each sample, and mixed vigorously in a
vortex. The diethyl ether fraction was then separated by centrifugation. The aqueous layer
(supernatant) was discarded and the organic phase was washed with portions of 5 mL citric
acid (0.1%, v/v) solution until clear. The organic phase from the samples was dried over anhy-
drous sodium sulfate. The organic solvent was evaporated with a rotary evaporator at 50˚C to
remove the dichloromethane. The unsaponifiable extract was dissolved in diethyl ether in a
conical vial and dried under nitrogen flow for the subsequent quantification of cholesterol and
COPs.
Analysis of total cholesterol by gas chromatography. For cholesterol determination,
10% of the unsaponificable matter solution was dried under nitrogen flow and subjected to
silylation according to Sweeley et al. [39]. A pyridine:hexamethyldisilazane:trimethylchlorosi-
lane (5:2:1, v/v/v) mixture was added (0.3 mL) and heated at 40˚C for 20 min. The mixture was
then dried under a stream of nitrogen and dissolved in 1 mL of n-hexane.
Analyses were performed on an Agilent 7820A gas chromatograph. 1 μL of sample was
manually injected in split mode (1:1). Separation of the compounds was performed on a Per-
kin Elmer PE-5 capillary column (30 m x 0.32 mm d.i. x 1 μm film thickness coated with 5%
-phenyl-methylpolysiloxane). The oven temperature was programmed from 280˚C to 300˚C at
a rate of 10˚C/min, and mantained for 30 min. The injection and detection port temperatures
were set at 325˚C. UHP nitrogen was used as the carrier gas at a rate of 1.5 mL/min.
Total cholesterol from the arterial tissue lipidic extracts was quantified by the internal stan-
dard method, using 5α-cholestane. Identification of the cholesterol peak in the samples was
carried out comparing the retention times with that from the standard. Quantification of cho-
lesterol was performed using a calibration curve.
Purification and derivatization of COPs. The remaining 90% of the unsaponificable
matter were dried under nitrogen stream and re-suspended in 300 μL of n-hexane:ethyl acetate
(95:5, v/v) and purified by NH2 SPE cartridges, previously equilibrated with 3 mL n-hexane
deied with anhydrous sodium sulfate at the bottom. The cartridge was eluted with the follow-
ing solvent sequence: 6 mL of n-hexane:ethyl acetate (95:5, v/v), 10 mL of n-hexane:ethyl ace-
tate (90:10, v/v) and 10 mL of acetone. The COPs were eluted from the NH2 SPE cartridge
with the acetone fraction according to the method of Rose-Sallin et al. [40]. The purified COPs
were dried under nitrogen flow and silylated, according to the method of Sweeley et al. [39],
and dissolved in 50 μL of n-hexane.
Analysis of COPs by gas chromatography. One microliter of the silylated COPs was
manually injected into the GC under the same conditions used for the determination of total
cholesterol. Total COPs were quantified using 19-hydroxycholesterol (19-OH) as internal
standard. The COPs identification in the samples was performed by comparison of the reten-
tion times with those of the COPs standards and the quantification was performed by calibra-
tion curves, as it was done for cholesterol.
Reagents
All analytical grade solvents and reagents were supplied by Tecsiquim (Mexico City) and from
Sigma-Aldrich (Mexico City). For identification and quantification of each COP the internal
standards utilized were 19-hydroxycholesterol (internal standard for the quantification of
COPs), 5α-cholestane (internal quantification standard for cholesterol), Cholest-5-en-3β-ol
(cholesterol), cholest-5-en-3β-ol-7-one (7-ketocholesterol), 5α,6α-epoxycholestane-3β-ol
Docosahexaenoic acid and cholesterol oxidation products
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(5,6α-epoxycholesterol), 5β,6β-epoxycholestane-3β-ol (5,6β-epoxycholesterol), cholestane-
3β,5α,6β-triol (cholestanetriol), cholest-5-en-3β,7β-diol (7β-hydroxycholesterol), and cholest-
5-en-3β,25-diol (25-hydroxycholesterol). Cholest-5-en-3α,7α-diol (7α-hydroxycholesterol)
standard was supplied by Steraloids (Newport, CT, USA).
Solid-phase extraction (SPE-NH2) cartridges (500 mg amino-propyl stationary phase/3
mL) were purchased from Phenomenex (Grace Discovery Sciences, Deerfield, IL, USA). The
silylation mixture was prepared with dried pyridine, hexamethyldisilazane and trimethylchlor-
osilane, from Sigma.
Statistical analysis
All values are expressed as the mean ± SEM (Standard Error of the Mean) of the five animals
used. For each value, the mean of the cholesterol and COPs quantification -obtained in each of
the two arteries from the same animal- was calculated. Statistical analysis of COPs concentra-
tion was performed by one-way analysis of variance (ANOVA) followed by Tukey’s multiple
comparison test. For body weight, statistical analysis was done using paired Student’s t-test. A
p value of less than 0.05 was considered significant. Data were analyzed using the GraphPad
Software (San diego, CA, USA).
Results
Animal body weight
Animals remained healthy and behaved similarly well throughout the experiment. Before the
experimental diets (control or DHA) were administered, body weight was evaluated in the
four groups of animals, showing no statistical differences among the groups (Table 2). The
average weight gain at the end of 8 weeks under the experimental diets was similar for all the
experimental groups, which is consistent with our previously published data [9].
Cholesterol content in aorta
Orchidectomy significantly increased cholesterol levels in the aortic tissue compared to the
control group fed with the control diet (Fig 1). The DHA-supplemented diet caused a signifi-
cant decrease in cholesterol levels in the aorta from orchidectomized animals. Samples from
control rats fed with the DHA-supplemented diet showed similar levels to those found in the
control rats fed with the control diet.
Table 2. Body weight (g) in control (C) and orchidectomized (ORX) rats fed with a control or DHA-sup-
plemented diet.
Body weight (g)
Animal group Before diet After diet
C Control 418.5 ± 11 463 ± 10*
C DHA 385.1 ± 12 435 ± 19*
ORX Control 384.6 ± 13 437 ± 12*
ORX DHA 409.2 ± 16 423.4 ± 16*
Values are means ± SEMs. Number of animals per group, n = 5.
*Indicates differences with its respective groups before diets.
https://doi.org/10.1371/journal.pone.0185805.t002
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COPs content in aorta
Total COPs levels significantly increased in the orchidectomized group, and decreased in orch-
idectomized animals fed the DHA-supplemented diet (Fig 1). DHA supplementation did not
stastically modify total COPs content in control rats.
Consistent with the above trend, orchidectomy caused a significant increase in the concen-
tration of the studied COPs in aortic segments: 7α-hydroxycholesterol (7α-OH), 7β-hydroxy-
cholesterol (7β-OH), 7-ketocholesterol (7-KC), 5,6β-epoxycholesterol (5,6β-E), 5,6α-
epoxycholesterol (5,6α-E), 25- hydroxycholesterol (25-OH), and cholestanetriol (CT) (Fig 1).
The DHA-supplemented diet decreased COPs levels in the aortic tissue of orchidectomized
rats, except 7β-OH which did not reach stastistical difference (Fig 1). However, the DHA-diet
to control animals tended to increase the concentration of all analyzed COPs.
Fig 1. Effect of orchidectomy and DHA suplementation on cholesterol and COPs content in rat aorta. Graphic representation of Chol and
COPs (7α-OH, 7β-OH, 7-KC, 5,6β-E, 5,6α-E, 25-OH, CT and total COPs) concentration in μg/g of lipids in aortic rings from control (C) and
orchidectomized (ORX) rats fed with a control or with a DHA-supplemented diet. Data were compared using one way ANOVA followed by Tukey‘s
multiple comparison tests. Values are means ± SEMs. Number of animals, n = 5. *Indicates a p < 0.05 vs Control group fed control diet. +Indicates a p<
0.05 vs orchidectomized rats fed control diet.
https://doi.org/10.1371/journal.pone.0185805.g001
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The proportion in the concentrations of the analyzed COPs in relation to the total COPs
was similar in the different groups included in this study. CT was the most abundant COP (ca.
30% from total COPs), followed by 7β-OH (ca. 20% from total COPs), 7α-OH (ca. 18%), 5,6β-
E (ca. 12%). 7-KC, was higher in both orchidectomized groups (fed with control and DHA-
suplemented diet) the ratio remained above the control groups by ca. 8–10%. The proportion
of 5,6α-E was similar in all groups, being ca. 5% of total COPs. 25-OH could not be detected in
the control rats fed the control diet and for the other groups this COP was detected in very
small concentrations (1%).
Cholesterol content in mesenteric artery
The content of cholesterol in mesenteric artery was significantly increased by orchidectomy
and the DHA-supplemented diet significantly decreased those levels (Fig 2). The DHA-diet to
control rats did not statiscally modify the content of cholesterol in mesenteric artery tissue
(Fig 2).
COPs content in mesenteric artery
Similar results were observed for COPs content in mesenteric artery respect to those found in
aorta from these animals. Total COPs content increased significantly in samples from orchi-
dectomized animals, compared to the rest of the groups. The control animals fed with the con-
trol diet as well as those fed with the DHA-supplemented diet showed similar COPs levels.
Again, DHA supplementation decreased COPs content in orchidectomized animals (Fig 2).
Orchidectomy significantly increased 7α-OH, 7β-OH, 7-keto, 5,6β-E, 5,6α-E, 25-OH, and
CT content (Fig 2) compared to the rest of the groups included in the study. As observed in
Fig 2, 25-OH content from control rats fed with the control diet was not detected. The same
ocurred with 7-KC, which was only detected in minimal amounts in the orchidectomized
group, whereas it was practically absent from the mesenteric artery tissue in the other groups.
In the mesenteric arteries from the orchidectomized animals fed with the DHA supple-
mented diet the concentration of COPs decreased significantly, except for 7β-OH, similarly to
that found in aortic tissue (Fig 2). DHA supplementation in control animals tended to decrease
the concentration of all the analyzed COPs (7α-OH, 7β-OH, 7-KC, 5,6β-E, 5,6α-E, 25-OH,
and CT), unlike the observed in aorta.
Regarding the distribution of COPs content in mesenteric artery tissue, CT was the most
abundant COP (ca. 30%) followed closely by the 7α-OH and 7β-OH, which showed similar
proportions between the same groups, arround 20% of total COPs. Next in proportion is the
5,6β-E representing ca. 15% of total COPs, with a slightly higher proportion in the control
group (19%). The 5,6α-E represents about 10% of the total COPs, dropping to 6% in the orchi-
dectomized animals fed the DHA-supplemented diet. 25-OH was practically absent, since it
could not be detected. In the case of 7-KC, it was only detected in the orchidectomized group
at very low concentrations.
Discussion
This study shows, for the first time, that the loss of gonadal function induced an increase in the
formation of COPs in both aorta and mesenteric artery wall. The preventive action of a DHA-
supplemented diet on the orchidectomy-induced COPs formation is also demonstrated. These
results are in agreement with data previously reported on both the effects of orchidectomy and
the beneficial role of a DHA-supplemented diet.
Regarding the results specifically associated to orchidectomy, we have previously reported
that the loss of gonadal function of rats induced an overproduction of ROS in aorta [3] and
Docosahexaenoic acid and cholesterol oxidation products
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mesenteric artery [4], as well as an increase in the serum content of cholesterol, LDL-choles-
terol and triglycerides [9]. It is known that the cholestesterol embeded on the lipid bilayer
from the cell membranes is prone to oxidation by ROS [41, 42] which could explain the
increased formation of COPs derived from autoxidation processes described in this work.
However, oxidation during sample processing can not be ruled out, despite of the utilization of
BHT (0.05%). Likewise, it is important to consider that conversion to COPs other than those
analyzed may exist. It is well known that the preferential site of oxidation of cholesterol by
highly reactive species is at C7 having a relatively weak carbon-hydrogen bond. Moreover, the
unique cholesterol double bond between carbons 5 and 6 comprises a vulnerable site for oxida-
tion by free radicals. The most abundant non-enzymatic cholesterol oxidation products pres-
ent in most tissues are 7α-OH, 7β-OH, 7-KC, and 5,6α-E and 5,6β-E, respectively [43, 44]
Fig 2. Effect of orchidectomy and DHA suplementation on cholesterol and COPs content in rat mesenteric artery. Graphic representation of
Chol and COPs (7α-OH, 7β-OH, 7-KC, 5,6β-E, 5,6α-E, 25-OH, CT and total COPs) concentration in μg/g of lipids in mesenteric artery rings from
control (C) and orchidectomized (ORX) rats fed with a control or with a DHA-supplemented diet. Data were compared using one way ANOVA followed
by Tukey‘s multiple comparison tests. Values are means ± SEMs. Number of animals, n = 5. *Indicates a p< 0.05 vs. Control group fed control diet.
+Indicates a p < 0.05 vs orchidectomized rats fed control diet.
https://doi.org/10.1371/journal.pone.0185805.g002
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induced by ROS and RNS [45], which is in line with the findings from the current study,
except for 7-KC, which was only detected in mesenteric arteries from orchidectomized rats.
CT is one of the most abundant oxysterols, derived from cholesterol by oxidation via forma-
tion of 5,6α-E and 5,6β-E as intermediates [46]. The very low detection leves of 25-OH may be
attributed to its primarily enzymatic origin, since this oxysterol is generally not considered to
be a significant autoxidation product of cholesterol. In addition, the reported levels of 25-OH
in most tissues are extremely low [36]. Determination of COPs content can vary depending on
the extraction and/or measurement methods, although very low COPs levels under physiologi-
cal conditions have been reported [47]. In this sense, the 7-KC, 7α-OH and 5,6α-E content
-referred to total cholesterol- reported in the present study were similar to those described in
human aorta [48] and coronary arteries [49]. However, the relative7-KC, 7α-OH, 7β-OH,
5,6α-E and 5,6 β-E content found in our study are higher than those described in human aorta
and carotid artery [49, 50].
On the other hand, COPs are known to trigger oxidative stress by increasing the generation
of superoxide anion [51, 52], and down-regulating the expression/activation of Nrf2 [53] Con-
sistent with these results, many studies have reported increased COPs levels in the membranes
of cells subjected to oxidative stress, as it has been detected in patients with diabetes mellitus
[54], hiperlipidemia [28], chronic inflammatory processes and chronic renal failure [55]. In
this regard, the oxysterol clearance mechanisms are probably less efficient in those situations
[44], as it was observed in orchidectomized rats in wich the antioxidant activity was decreased
[9]. Zhang et al. [56] demonstrated that castration decreased enzimatic antioxidant activity
(SOD and glutathione peroxidase) and increased malondialdehyde levels, an indicator of lipid
peroxidation. In contrast, other studies found that castration did not increase lipid peroxida-
tion [57]. These discrepancies could be attributed to differences in the animal model used,
since the maintenance period of gonadectomy determines the induced alterations [8, 58].
However, it is important to emphasize that the experimental model used in this study is the
same as that used in our two previous studies [9, 10] and provides relevant information about
the key role of the COPs in the orchidectomy-induced modifications of factors, additional to
ROS, which regulate vascular function.
It has been mentioned above that different cardiovascular risk factors, such as hypertrigly-
ceridemia, hypertension, diabetes, obesity and overweight, have been associated to COPs con-
tent in human serum [15]. In agreement with these results, COPs induced increased blood
pressure, serum triacylgycerols as well as body fat index in Wistar rats [59]. On the other hand,
the induction of hypertension to rabbits by coarctation of the aorta showed an enhancement
of COPs content in both plasma and aortic tissue [60]. In addition, Ares et al. [61] indicated
that COPs promoted the stimulation of MAPK in human aortic smooth muscle cells, which
could partially explain the activation of the MAPK sinaling pathway reported in hypertension
after tyrosin kinase receptor transactivation [62]. In this regard, our group has described the
activation of MAPK and AKt pathways in mesenteric arteries of orchidedctomized rats, in
which the transactivation of EGFR was involved [8]. In this context, these results would indi-
cate that the increase in the formation of COPs may participate in the orchidectomy-induced
structural alterations that, in the long term, can lead to the development of hypertension, as it
occurs in aged-orchidectomized rats.
Apart from these effects, COPs alter prostaglandin synthesis and stimulate platelet aggrega-
tion, an important process facilitating atherosclerosis and thrombosis [42]. Likewise, different
COPs induced the expression of COX-2 [63] and the release of prostaglandin E2 [64] and pros-
taglandin J2 [65], considered as pro-inflammatory events. Accordingly, it has been described
that orchidectomy also leads to a pro-inflammatory environment by increasing prostanoid
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production in rat aorta [6, 8, 9] and mesenteric arteries [7, 8, 10] most likely as a consequence
of increased oxidative stress produced during the experimental conditions.
Nitric oxide is also a critical molecule in vascular function, and the inhibition of endothelial
NO-synthase by COPs has been described [52, 66], which is also in agreement with the
decreased NO formation observed in aorta [9] and mesenteric artery [10] from orchidecto-
mized rats. Although the decrease of NO production by COPs seems to be demonstrated, stud-
ies addressing the influence of COPs in the vascular function have shown contradictory
results, since inhibition [67, 68] or no modification [69, 70] of endothelial-dependent vasodila-
tion by 7-KC and 7α-OH-cholesterol have been reported. In our experimental model, orchi-
dectomy did not alter the acetylcholine-induced response in aorta or mesenteric artery, since
factor/mechanisms other than NO are simultaneously working to maintain a proper function
[4, 7].
These results can be summarized in that orchidectomy induced an increase of the oxida-
tive stress and anti-inflammatory mediators, and a deterioration of the lipid profile, which is
accompanied by an increase in the formation of COPs. Interestingly, cholestanetriol -the
most abundant COP in all samples, especially in arteries from orchidectomized rats- has
been reported to be one of the most cytotoxic oxysterols in different cell lines such as rabbit
aortic smooth muscle cells [71], mouse L cells [72], Chinese hamster V79 lung fibroblasts
[26], human monocytic cells (U937), colonic adenocarcinoma cells (CaCo-2) and hepatoma
liver cells (HepG2) [73]. However, it is important to point out the cytotoxic effects reported
for different COPs other than cholestanetriol, also in different cell lines, related to vascular
and nervous systems that contribute to the pathogenesis of cardiovascular [52, 74] and
neurodegenerative [19, 20] diseases.
It has been suggested that generation of some oxysterols can be reduced in the presence of
antioxidants [43] by scavenging ROS. For instance, supplementation of vitamin E to diabetic
patients can decrease 7-KC and 7β-OH levels [75]. Likewise, Uemura et al. [76] found that
apoptosis induced by 7β-OH and 7-KC in vascular endothelial cells was prevented by α-
tocopherol. DHA exhibits potent anti-oxidant properties which attenuate ROS overproduction
in endotelial cells [77] and enhances the overall antioxidant status [78]. Recently, the ability of
DHA to prevent ROS overproduction and oxiapoptophagy induced by 7KC, 7β-OH, and
24-OH in oligodendrocytes was demonstrated [79]. De Medina et al. [80] found that DHA
inhibited cholesterol-5,6-epoxide hydrolase activity, that catalyzes the conversion of 5,6α-E
and 5,6β-E to its product CT, which exerts important citotoxic effects. Also, DHA showed pro-
tective effects on COPs-induced cell death [33]. These results agree with our findings, since the
DHA-supplemented diet to orchidectomized rats prevented the rise in COPs formation caused
by orchidemtomy. Thus, the levels of COPs were near to those measured in control rats fed
the control diet. Interestengly, the DHA-supplemented diet restored the increased contents of
COPs induced by orchidectomy, similarly how it restores the lipid profile, and the redox and
inflammatory status altered in this particular condition [9,10]. These results are in agreement
with the cardioprotective effects of DHA widely reported through its anti-inflammatory [31]
and anti-oxidant activities [33–35]. It has been recently reported that DHA, one of the main
fatty acids of the Mediterranean diet, attenuates the 7-KC-induced toxic effect on microgial
cells [81]. Based on all this information, human dietary habits deserve important consideration
and comsumption of a Mediterranean diet could prevent the consequences of an increased
oxidative stress that occurs in diverse physiopathological situations. However, something dif-
ferent seems to occur with the DHA-supplemented diet to the control animals, in which a ten-
dency to increase COPs content was observed in the rat aorta. This result is in line with a
previous report, in which the involvement of vasodilator prostanoids in the Ach-induced
response in aorta from control rats was switched to vasoconstrictors after the DHA-
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suppelemented diet [9]. Overall, these results indicate that DHA-supplementation exerts cardi-
opotective effects, especially in pathological conditions, which seems to be reasonable since the
homeostatic mechanisms work to maintain proper function in healthy subjects without any
nutritional supplement.
In summary, we describe here the detrimental effects caused by the lack of sex hormones in
the rise in lipid peroxidation, providing new information on the damage on lipid components
responsible of maintaining membrane properties and cell signaling in different pathways
involved in the vascular function of aorta and mesenteric artery, already published [9,10]. The
preventive effect of a DHA-supplemented diet on lipid peroxidation, which promotes the
maintenance of vascular homestasis, is also shown. In this regard, it is important to note that
the results observed in the mesenteric artery, together with those related to vasomotor function
[10], are of special relevance since this vascular bed importantly contributes to the control of
the peripheral vascular resistance and therefore to the regulation of blood pressure. The pres-
ent findings reveal the interest in conducting clinical studies with DHA in patients with
decreased levels of sex hormones (elderly patients and/or prostate cancer patients undergoing
androgen deprivation therapy) who display cardiovascular risk factors.
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